To assess the sweating capacity in hum an poikilothermia, we performed a quantitative analysis of the central and pe ripheral sudomotor pathways in four women with acquired poikilothermia (aged 29 to 38 years) and nine controls. Heat challenge in a climatic chamber (ambient temperature 40 °C, 50% relative humidity) for 180 minutes revealed that both sweat secretion and evaporative weight loss were significantly lower in the patients than in the controls (p < 0.01). Temperature thresholds for thermal sweating were markedly elevated in at least two patients, whereas a third patient showed no sweating response. Stimulation of the eccrine sweat glands by intradermally injected acetylcholine during reduced core temperature (34.9 ± 0.7 °C) revealed a significantly reduced sweating response in all patients (p < 0*01); the sudomotor response to pilocarpine iontophoresis was reduced or absent in three patients. We conclude that the generalized thermoregulatory sudomotor failure in these patients was attributable primarily to disorders of the central sudomotor drive; the impaired postganglionic sudomotor response is temperature related and possibly sec ondary to (long-standing) poikilothermia. Quantification of he at-dissipating capacity is pivotal for diagnosing severe thermolability and may help to prevent serious heat illness. NEUROLOGY 1995; 45:1602 -1607 Human thermoregulation is achieved by a complex interaction of autonomic, endocrine, and behavioral responses; the skin plays an im portant role in both afferent and efferent therm oregulatory pathways. H um ans have a lim ited physiologic capacity to w ithstand cold stress but can dissipate heat most effectively, principally by sweating and peripheral vasodilatation. If am bient tem p eratu re exceeds body surface tem perature, the only mechanism to m aintain therm al equilibrium is evaporative heat loss; evaporation of 1 liter of sw eat can remove 2,450 k J (585 kcal). The control of therm al sweating is influenced by inform ation from central and peripheral therm o receptors and is coordinated predominantly by the preoptic area/anterior hypothalam us1-3; the efferent sym pathetic sudom otor function is m ediated by both p reganglionic cen ters and postganglionic cholinergic pathways. 4 Poikilotherm ia, defined as fluctuation in core tem perature of more than 2 °C due to changes in the ambient tem perature, is the most common dis order of thermoregulation in humans and is usually caused by lesions of the posterior hypothalamus or b ra in s te m ,5 b u t its p ath o p h y sio lo g y rem ain s largely unknown. The disorders of heat production and heat conservation in poikilothermic patients predispose to marked hypothermia."'0 However, if the preoptic region or peripheral heat-dissipating pathways are also affected, the patients are suscep tible to severe hyperthermia, including heat stroke, particularly in combination with inadequate behav ioral thermoregulation and possible use of drugs that suppress sudomotor function.n Decreased sweat secretion during supranormal core temperature has been reported in some patients with poikilother mia7'13; however, the sudomotor capacity in poikilo thermia has not yet been quantified.
We investigated the heat-dissipating m echa nisms in four patients with acquired poikilother mia, most probably of hypothalam ic origin. We have previously demonstrated th at our patients meet the definition of poikilothermia/5, 7 We recently reported on the thermoregulatory responses to cold and heat challenge in our patients0 including some data on thermal sweating that are also described in the present study.
The rationale for the current study was to inves tigate the functional integrity of the central and pe ripheral sudomotor pathways by quantitative as sessment of thermoregulatory sweating and post ganglionic sudomotor responses in our patients.
Methods. Sichjccts, We investigated four women, (aged 29 to 38 years) with acquired poikilothermia. All patients bad a normal history of thermal sweating previous to the occurrence of poikilothermia but reported absence of sweating since then.
Patient 1 was a 29-year-old woman who was treated in 1983 by surgery and radiation therapy for a large tumor near the corpus callosum with bilateral extension into the suprasellar cisterns; pathologically, no distinction be tween dysgerminoma, neuroblastoma, or atypical pineoblflstoma could be made. Postoperatively, she exhibited epilepsy, frontal lobe syndrome, and hypothalamic dys function, including partial diabetes insipidus, reduced thirst perception, increased appetite, hyperprolactinemia, and poikilothermia. Dependent on ambient temperature' physical activity, and behavioral thermoregulation, core temperature was most of the time between 35.0 and 88. 6 °C. On hot summer days core temperature exceeded 40 °C, causing progressive drowsiness, confusion, restless ness, and decreased consciousness; no sweating has been noticed since 1983. P atien t 2 was a 38-year-old woman with no relevant medical history until 1982, when epilepsy, secondary amenorrhea, and poikilothermia were demonstrated. Neuroendocrinoiogic evaluation revealed no well-known causes of thermolability; CT and MRI of the cerebrum showed no evidence of hypothalamic or pituitary lesions. Core temperature ranged from 31,4 to 35.2 °C and in creased up to 38.2 °C during exposure to a hot environ ment without provoking visible sweating. P atient 3 was a 34-year-old woman in whom panhypopi tuitarism and marked thermolability were demonstrated in 1982. MM of the cerebrum in 1990 showed an empty sella. Core temperature ranged from 32,9 to 37.0; eleva tion up to 38 °C induced severe discomfort, agitation, confusion, and impaired judgment but no sweating. P atien t 4 was a 31-year-old woman who suffered from epilepsy, post-traumatic encephalopathy, and marked hypothermia after extensive cerebral damage due to a traffic accident at age 16, CT of the cerebrum in 1978 re vealed marked central atrophy of the hemispheres, in cluding bilateral thalamic lesions. Core temperature usu ally varied from 31.7 to 36 °C but increased up to 36 to 37 °C during the 4 months preceding the present study, presumably due to ameliorated control by her environ ment. Sweat secretion was never observed.
The patients received no anticholinergics or other medi cation known to interfere with sweat secretion, except for patient 4, who was treated with carbamazepine 200 mg per clay throughout this study and clomipramine up to 4 weeks before this study. A more detailed description of the clinical and biochemical data of our patients has been published elsewhere.
Nine healthy women, matched for age and body mass index, served as controls for the patients; the physical characteristic« of all participants are listed in the table. All controls had a normal history of thermal sweating and did not use any medication. To reduce possible effects of the menstrual cycle on the sweat response, all controls and the two nonamenorrheic patients (nos, 1 and 4) were studied during days 5 to 11 of the menstrual cycle. None of the participants was acclimated to heat stress. The experimental procedures were approved by the Local Ethical Committee; informed consent was obtained from all participants.
Investigations. Thermoregulatory sweat test.
Preceding heat exposure, baseline values (vide infra) were obtained in a thermoneutral climatic chamber (ambient tempera ture [Tarab] 29 °C, 50% relative humidity) during 50 min utes after a 45-minute acclimatization period, All sub jects were investigated in supine position on a comfort able examination table, dressed in bikini, and were al lowed to drink limited amounts of tepid water. The wind velocity was less than 0.1 m/sec. Assessment of the he at-dissipating capacity was per formed during a 180-minute exposure to intense heat stress in a climatic chamber (Tamb 40 °C, 50% relative hu midity). To avoid severe discomfort and heat illness, thermal stress was terminated if rectal temperature (Tr ) exceeded 38.5 °C.
To estimate the total weight loss due to sweating, the body weight was recorded on a precision balance (accu racy, ±5 g) preceding and immediately after heat stress, after drying the patient with a towel. The total evapora tive weight loss was assessed by continuous recording of changes in total body weight by means of a Potter bed balance (accuracy, ±5 g). Changes in body weight were corrected for intake of liquid as well as respiratory and metabolic weight loss, according to Snellen.14 For 50 min utes before heating and during heat stress, the local evaporation rate was recorded every 10 minutes by means of an evaporimeter16 (Evaporimeter Epl, Ser-voMed AB, Stockholm, Sweden) applied to five sites: forehead (a), chest (b), abdomen (c), ventral thigh (d), and ventral forearm (e). Based on the relative areas of body surface of DuBois,16 the weighted mean local evapo ration rate (Evaploc) was calculated according to Evaploc = 0.1029a + 0.2574(b + c) + 0.2794d + 0.1029e.
Rectal temperature was recorded simultaneously by means of a probe with thermistor (depth of insertion, Acetylcholine test. The response of eccrine sweat glands to intradermally injected acetylcholine was deter mined at room temperature (Tamb ± 22 °C), normal rela tive humidity, and minimum air convection; both pa tients and controls (see above) were wearing standard clothing. Local evaporation was recorded continuously by means of an evaporimeter for 10 minutes before and 60 minutes after pharmacologic sweat stimulation. Acetyl choline (0.1%/0.1 ml) was injected on the flexor surface of the forearm (approximately 10 cm distal to the elbow), with an indwelling intradermal 25-gauge needle, by the same investigator in all cases. The epidermis was perfo rated outside the actual measuring site; the drug was in jected after the needle was moved approximately 1 cm intradermally into the test site center. Peak and total (ex pressed as area under the curve, corrected for baseline values) evaporative responses to acetylcholine were as sessed. The rectal and local skin tem peratures were recorded with thermistors; due to technical limitations this was performed only in the patients.
To examine the effect of normalization of core temper ature on sudomotor function, testing the sweating re sponse to acetylcholine was repeated in two patients (nos. 2 and 3) after several days of steady state normothermia, which was achieved by a higher ambient tem perature, increased insulation, and use of an electric blanket.
Pilocarpine test. The sweat response to pilocarpine on the contralateral forearm at the corresponding site was determined simultaneously with acetylcholine testing. Pilocarpine nitrate (Ionto-Pad, Orion Research Inc, Cam bridge, MA) 1% was administered by iontophoresis for 5 minutes with 2 mA direct current from an Orion (model 417, Orion Research Inc) potentiometer. Thereafter, the quantity of the sweat response of the stimulated area for 45 minutes was estimated by means of a Macroduct cap illary collection device (Wescor Instruments, Logan, UT).
Sweat gland biopsy. To assess whether putative sudo m otor d y sfu n ctio n w as re la te d to h isto p athologic changes, supra-iliac skin biopsies were performed in two patients (nos. 2 and 3).
S ta tistic a l a n a ly sis. The Wilcoxon rank sum test was applied for comparison of the sweating responses with thermal stress and pilocarpine iontophoresis between pa tients and control subjects. Regarding the sweating re sponse to acetylcholine, intra-and intergroup compar isons were performed by repeated m easures ANOVA with multiple comparison procedures by means of the contrast option of the General Linear Models procedure (SAS Institute Inc, Cary, NC; p value in this case de noted by p*). Values of p < 0.05 were considered to indi cate statistical significance. The results are expressed as means ± SD unless indicated otherwise.
R esu lts.
Thermoregulatory sweat test All partici pants were exposed to heat for 180 minutes; only in p atien t 2, h e a t stress was term inated after 120 minutes (due to distress and Tr exceeding 38.6 °C). At the end of therm al stress, both total body weight reduction (646 ± 103 g [range, 459 to 780] versus 101 ± 102 g [range, 26 to 247], p < 0.01) and evapo rative weight loss (407 ± 61 g [range, 312 to 530] versus 64 ± 67 g [range, 18 to 162], p < 0.01) were 1604 NEUROLOGY 45 A ugust 1995 significantly greater in the controls than in the pa tients.
At thermoneutrality, the local evaporation rate was comparable in the patients and controls (8.6 ± 3.2 g/m2h versus 9.6 ± 2.5 g/m2h, p = ns), despite significantly lower Tr (35.3 ± 0.3 °C versus 37.0 ± 0.3 °C, p < 0.01) and T^evan) (33*2 ± O-7 °C versus 34.3 ± 0.4 °C, p < 0.05) in the patients. In all con trols, sweating started within 5 minutes after the beginning of heat exposure; in contrast, in the pa tients either no sweating occurred (patient 1) or the sweating response was markedly delayed and re duced. The relation between the onset of sweating and both Tr and Tskin is depicted in figure 1 . Sweat ing in patients 2 and 3 started after 60 minutes heating (Tskin(evap) 37.7 °C in patient 2 and 37.0 °C in p atien t 3) and in p a tie n t 4 after 130 m inutes (Tgkin(evaP) 37.8 °C). The sweat response was limited to th e forehead and upper torso in p a tie n t 2, whereas patients 3 and 4 showed more generalized thermal sweating. Patient 1 showed no increase in evaporation rate despite core and skin tem pera tures exceeding 38.5 °C.
Acetylcholine test The sweating response to in tradermal injection of acetylcholine is depicted in figure 2 . The evaporation rate in the controls in creased significantly from 8.8 ± 3.9 g/m2h to a max imum of 196.9 ± 22.6 g/m2h (range, 170 to 234; p * < 0.0001); compared with baseline value, the evapo ration rate remained significantly enhanced during the entire recording.
The evaporation rate in the patients increased significantly after acetylcholine injection from 6.5 ± 4.0 g/m2h to a maximum of 78.5 ± 38.6 g/m2h (range, 32 to 115; p* < 0.05). However, the maxi mum evaporation rate was significantly decreased in the patients as compared with the controls (p < 0.01); the same applied to the cumulative response to acetylcholine ( 1.7] ). The max imum evaporation rate in the patients was reached at approximately the same time after stimulation as in the controls but was delayed in patient 4.
Normothermia in patients 2 (Tr 36.9 °C) and 3 (Tr 36,5 °C) induced a rise of 0.6 °C (patient 2) and 0.9 °C (patient 3) in local skin temperature and an increase in maximum evaporation rate from 32 to 80 g/m2h (patient 2) and from 105 to 134 g/m2h (pa tient 3).
Pilocarpine test, Pilocarpine iontophoresis in duced a secretion of 32,6 ± 11.4 (jlI (range, 20 to 57,5) sweat in the controls during a 45-minute period. The sweating response to pilocarpine was attenuated in three patients (0 jol, patient 1; 0 jxl, patient 2; and 15 fxl, patient 3) but markedly enhanced (70 ( 
O from preganglionic or central lesions by testing both the thermoregulatory sweating and sudomotor reflex. The sy m p ath etic sudom otor response to acetylcholine is m ediated by both muscarinic and nicotinic receptors, whereas pilocarpine is consid ered to bind directly to the muscarinic receptor on the eccrine sweat gland.4,25 Although the sweating response to pilocarpine was m arkedly blunted or absent in three patients, the positive (although re duced) response to acetylcholine in all patients in dicated an at least partly intact local sympathetic supply. Patients with more serious impairment of therm al sweating also showed lower sweating re sponses to cholinergics. The enhanced sudomotor response to pilocarpine in p atien t 4, despite re duced therm al and acetylcholine-induced sweating, might be attributed to supersensitivity of the mus carinic m echanism s by carbam azepine or w ith drawal of clomipramine. 26 The sudomotor responsiveness to cholinergics is affected by local skin and core tem peratures,4,27* 28 notably mediated by the rate of transm itter release at the neuroglandular junction and degree of glan dular response. 21 The impaired cholinergic sudomo tor response in the patients might be attributable to the reduced core and (local) skin tem perature at the tim e of the test. However, the sudomotor re sponse to acetylcholine in patients 2 and 3 during norm otherm ia rem ained subnorm al. The atten u ated sudomotor response might be caused also by impaired secretory capacity or decreased number of active sw eat glands due to functional inactivity during prolonged periods of hypotherm ia, which might be considered as a counterpart of heat ac clim atization in therm al sweating after a rise in body tem perature.29 However, no histologic abnor malities were found in sweat gland biopsies. Gener alized hypohidrosis and a decreased postganglionic sudomotor response can be caused by generalized autonomic failure, m ultiple system atrophy, vari ous drugs, and m any chronic (skin) disorders30-34; however, in our patients these causes were not re sponsible for the sudomotor dysfunction. Therefore, we hypothesize th a t in addition to the reduced core and local skin tem perature, long-standing absence of adequate sudom otor stim ulation and possibly secondary degeneration of sudomotor axons may contribute to the acquired sudomotor failure.
Because anhidrosis may easily be misdiagnosed in the case of rapid invisible sweat evaporation,19 quantitative analysis of sweating capacity is a pre requisite to establish thermoregulatory sudomotor failure, which may occur in combination with an in tact cholinergic sudomotor response. Continuous recording of the evaporative weight reduction is ad equate to assess to ta l h e a t d issip atio n ,17-20 and recording the local evaporation ra te at m ultiple sites makes it possible to assess topographic differ ences. If inadequate therm oregulatory sw eating has been dem onstrated despite supranormal tem peratures of core and skin, the sudomotor response to cholinergics m ust be assessed complementarily 1606 NEUROLOGY 45 A ugust 1995 to differentiate between postganglionic and pregan glionic or central lesions. Additionally, sudomotor analysis during prolonged physical exercise may be useful, but this failed to induce an increase in ther mal sweating during either hypothermia or nor mothermia in our patients (unpublished data). Fur thermore, impaired heat dissipation can be caused partly by inadequate skin vasodilatation; based on marked reddening of the skin and the high skin blood flow during heat stress,6 this obviously was not the case in our patients.
The present study has some limitations. First, during thermal stress, core and skin temperatures all changed simultaneously and were recorded in termittently, thereby hampering exact determina tion of core and skin tem perature thresholds for thermal sweating. Second, at the start of heating, rectal and mean skin tem perature were lower in the patients; however, even after the onset of ther mal sweating, the rate of evaporative weight loss remained much lower in patients than in controls. Third, local skin temperature was not recorded in controls during testing of the cholinergic sudomotor response; however, the local skin tem perature of the forearm in the thermoneutral climatic chamber was only 0.7 °C lower in the patients than in the controls, making it unlikely that this variable sig nificantly influenced the differences in sudomotor response. Fourth, the high humidity and low air ve locity during heat stress decreased the evaporative capacity. However, based on previously observed absence of visible sweating,7 the high heat load was necessary to differentiate between anhidrosis or merely elevation of the temperature thresholds for sweating. Furthermore, the exact location of the heterogenic preganglionic lesions remains uncer tain, and adaptation of the thermal-and choliner gic-induced sudomotor response to long-standing normothermia requires further elucidation. Ther mal sweating and sudomotor responses might be improved by prolonged normothermia, especially if combined with interm ittent heat stress, physical training, or drugs that enhance sweating.
Decreased thermostability and hypohidrosis pre dispose to serious heat illness in a hot environment, especially in combination with physical exercise, in adequate behavioral thermoregulation, dehydra tion, or chronic (cardiovascular) disorders.3,4,6'32'35 Recognition of impaired heat tolerance is often diffi cult6* 10* 36-particularly in patients with poikilother mia who tend to have prolonged hypothermia in cold and moderate climates-but is pivotal for diag nosing poikilothermia and for differentiating be tween hyperthermia and fever.:,r> ,:17 Because anhidro sis may indicate generalized thermoregulatory fail ure with potentially serious sequelae,a careful history and investigation of the sweating capacity and putative precipitating disorders is indicated in hyperthermia without obvious cause. The diagnosis of poikilothermia should be taken into account in patients with decreased thermostability, especially if other autonomic or endocrine disorders exist. In poikilothermia, considerable fluctuations in core temperature greatly affect physical and neuropsy chiatrie function, and adequate monitoring of core temperature and amelioration of thermoregulatory behavior may help to prevent serious complications of both hypothermia and hyperthermia.
Our results demonstrate generalized deficiency of thermoregulatory sweating in our patients with acquired poikilothermia, attributable primarily to a defect in the central thermal drive; the impaired postganglionic sudomotor response is partly related to the lower core and skin temperature and possi bly also to (longstanding) absence of sudomotor stimulation. We emphasize that a careful history and quantitative assessment of sweating capacity in patients with heat intolerance is essential to rec ognize serious hypohidrosis or generalized ther moregulatory failure and can thereby help to pre vent the complications of severe hyperthermia.
